Get started

2019

Corona(Covid 19 vaccine) stock that can explode in 2021A little-known biotech is trying its hand at developing a coronavirus vaccine. Can it succeed? over the past year, Vaxart stock has soared over 1,250% because of its spot in the lucrative coronavirus vaccine race. Its stock performance even outpaced those of biotechs that have already brought their coronavirus vaccines to market, such as Moderna and BioNTech. In fact, over 30% of Vaxart stock has been sold short. Vaxart claims to have created an experimental coronavirus vaccine in the form of an oral tablet. One could potentially self-administer the vaccine pill, which is stable at room temperature. This would allow patients to order the vaccine online and have it delivered for at-home use. At the moment, Vaxart's experimental coronavirus vaccine is only in phase 1 clinical trials, with a new data readout expected by next week. Unfortunately, it's impossible to conclude how the experimental vaccine will work on humans from animal models. Hence, the candidate's phase 1 data release will likely be a make-or-break moment for Vaxart. Vaxart is under investigation by both the U.S. Securities and Exchange Commission (SEC) and the Department of Justice (DOJ) for insider trading and inaccurate statements regarding its role in Operation Warp Speed (OWS). Even though Vaxart has more than $133 million in cash and equivalents with no debt whatsoever, that's not nearly enough to move forward. Right now, it could cost billions of dollars to run a potential coronavirus vaccine through clinical trials involving tens of thousands of participants. The company will likely sell more stock to pay for its research and development (R&D) expenses or apply for grant funding -- just to stay afloat. Vaxart is far riskier than the other coronavirus vaccine drugmakers out there. Its corporate conduct is under federal investigation, and its vaccine candidate is in far too early a stage to draw any definitive conclusions about. With a market cap just south of $1 billion, it will undoubtedly become a very undervalued stock if it can bring a coronavirus vaccine to market. Moderna, which has done so, projects $11.7 billion in revenue from its mRNA-1273 vaccine alone. However, the probability of Vaxart achieving anything remotely similar is up for debate. Short-sellers and passionate bulls will be arguing over the stock for the next year. If you believe in Vaxart's science and have the stomach for a roller-coaster ride, then go for it.
NASDAQ:VXRT
by AlenCiken
COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 TrialNovavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial First to Demonstrate Clinical Efficacy Against COVID-19 and Both UK and South Africa Variants Strong efficacy in Phase 3 UK trial with over 50% of cases attributable to the now-predominant UK variant and the remainder attributable to COVID-19 virus Clinical efficacy demonstrated in Phase 2b South Africa trial with over 90% of sequenced cases attributable to prevalent South Africa escape variant NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase 3 clinical trial conducted in the United Kingdom (UK). Novavax also announced successful results of its Phase 2b study conducted in South Africa. Significant progress on PREVENT-19 Clinical Trial in US and Mexico finance.yahoo.com
NASDAQ:NVAX
by AlenCiken
COVID-19 Wave 2 trajectory still ongoing... SD, MY, ID and CNFirst up... obvious from November 2020 that Singapore was already heading towards a spike/Wave2. After so long, appears sthat the inevitable is happening, and projecting forwards, by end Feb or early March, the MACD histogram would be positive. Note that this has had happened to China, obvious int he MACD histograms since Octoboer 2020, through to December 2020 and has prompted localized lockdowns in the NorthEast of China. Malaysia and Indonesia unfortunately are not seeing any reprieve... not surprising, given the measures taken, too little too late, if at all. This eventually will pose problems for Singapore. No change in the trejectory as outlined months ago...
C
by Auguraltrader
Hyperinflation aheadOil the biggest traded commodity globally by far and therefor best indicator to detect commodity price inflation imho. From Investopedia artikel Why Didn't Quantitative Easing Lead to Hyperinflation? the following snippet: "During the Great Recession banks still had bad loans and toxic assets on their balance sheets as a result of the housing bubble burst and its aftershocks. While the central bank did increase the money supply sharply, banks used these funds to shore up their balance sheets and buffer toxic assets, rather than creating new loans." Expecting the banks to have continued with this responsible business model, hyperinflation will fall upon the world economy straight out of the blue imho. Very well possible the reason why the UJ Seasonality opening bell has us waiting since March '18 for its continuation. A confluence of circumstances leading up to the great recession of 2008 included economic disruptions such as SARS and a CDO housing bubble, a repeat of quite a similar series of events likely to unfold with COVID marking the start of it all..
TVC:USOILLong
by Deep-Peat-Shark
2
EDSA to Study Investigational Drug as Potential Rescue TheraphyEdesa Biotech to Study Its Investigational Drug as Potential Rescue Therapy EDSA has received regulatory approval from the U.S. Food and Drug Administration (FDA) and Health Canada to add a sub-study to its ongoing Phase 2/Phase 3 clinical study of its investigational drug, EB05, for the treatment of Acute Respiratory Distress Syndrome (ARDS) - the leading cause of death in COVID-19 patients. The sub-study will evaluate the drug as a potential rescue therapy for critically severe COVID-19 cases. This sub-study will allow us to potentially expand the use of EB05 to critically ill patients suffering from profound, medically refractory COVID-19 respiratory failure," Dr. Nijhawan said. finance.yahoo.com
NASDAQ:EDSA
by AlenCiken
S&P: Why your shorts aren't winningHave you been shorting this bull market wondering why you're not winning? I've been getting direct messages asking me when is it a good time to short or why when there is a reversal candle there is no follow through to the downside. Zooming out to the 2 day chart I think you can see why. We are in a massive uptrend channel since early last year right after the big COVID drop. THE TREND IS YOUR FRIEND As of today, I would not be trying to short or even go long. I think the market is too risky and is coming up to heavy resistance. We need a big pullback before I think the S&P becomes attractive. Where is that pullback? I may end up waiting to see it pullback closer to the bottom of the channel (with retest) to go long. I'll also take a breakout of the top of the channel (with retest). Why not short when it reaches to the top of the channel? We are in a strong uptrend and going short is not recommended. Some may take the short at the top of the channel and be rewarded. It's just not my type of trade. I like trades with higher probability. Hopefully this view makes it much more clear why if you've been shorting the market since March 2020, you have been on the wrong side of the trade. I will be a seller if the bottom of the channel breaks to the downside (with retest). Then I think shorting will become attractive. Good luck trading. "When it feels really right it's probably wrong and when it feels really wrong it's probably right."
OANDA:SPX500USD
by XYZ-Trader-
5
BTCUSD: Same 2019 Fractal To Look Out ForHard not to notice the similarity in the parabolic run from this winter compared to 2019. I hadn't considered this fractal until I matching them up. Both bull runs come from the lower bands of the logarithmic growth curves to around the mid-band, with approximately a +250%. This would imply a 6-month long down-trend extending to a 50% correction. Therefore re-test of $20K could on the cards, possibly as low as $18K if the fractal continues, while remaining long-term bullish.
BNC:BLXShort
by dragononcrypto
AditxtScore™ Immune Monitoring Service Operational on February 1AditxtScore™ Immune Monitoring Service Will be Operational on February 1st Company Plans to Offer Service through Channel Partners The initial application of the platform will be AditxtScore™ for COVID-19 which has been designed to provide a more complete assessment of an individual’s infection and immunity status with respect to the SARS-CoV-2 virus. We’re currently in discussions with labs, hospitals and other channel partners around the world interested in incorporating AditxtScore™ into their offerings. finance.yahoo.com
A
by AlenCiken
Adamis Surges After Submitting Covid Drug to FDAAdamis Pharmaceuticals Announces IND Submission to FDA for Tempol for the Treatment of COVID-19 announced today the submission of an Investigational New Drug (IND) to FDA for the investigational use of Tempol for the treatment of Coronavirus (COVID-19). The submission of the IND to FDA followed a Pre-IND meeting with FDA in which FDA gave specific recommendations on Chemistry, Manufacturing and Controls (CMC) and Clinical aspects to be included in the IND. The Company plans to seek government and/or non-government funding to study the treatment and prevention of COVID-19 with Tempol. Tempol has demonstrated both potent anti-inflammatory, anticoagulant, and antioxidant activity. finance.yahoo.com
A
by AlenCiken
1
GILD - The Sleeping Giant - Trend ReversalGILD - The Sleeping Giant - Trend Reversal ___________________ ENTRY = 56.56 Double Bottom - +64 confirmation 1st Target = .236fib@72.33 2nd Target = .382fib@82.08 3rd Target = .5fib@89.97 HOLD Target = .618@97.85+ JAN22 Call Leaps Still cheap ________________________________________________________________________________________________________________________ This content is for informational and educational purposes only. This is not in any way, shape or form financial or trading advice. Good luck, happy trading and stay chill, 2degreez
NASDAQ:GILDLong
by UnknownUnicorn7216011
COVID-19 Wave 2 onset and ongoing... SG, MY, ID and CNAs posted weeks to months ago, it is becoming clearer than daylight that Wave 2 is upon us in 2021. As described previously, the CONFIRMNED charts here have a peciliarity... that the MACD histograms hint of the trend months ahead in advance. As observable, Singapore is currently maanging pretty well, but is heading towards a Wave 2 slowly and surely. The trend is telling us that for the past 16 weeks (4 months) already!!! SG's neighbours Indonesia (lower left) and Malaysia (lower right) have been having trouble keeping the lid on it... with Indonesia experiencing Wave 1.2, and Malaysia in a massive Wave 2. China, top right, had a similar build up to SG and is pretty much in a mild Wave 2 currently. Clearly, showing the path of what to expect as Singapore is heading down the same road. 16 weeks of notice, and nothing solid is being done to stop the wave from reaching. At this rate, by about Chinese New Year, SG should be in Wave 2 proper. In any case, pretty much the whole world is sinking into Wave 2 already... Contrary to the main belief, the vaccine availability, intended to slow down the spread, may actually allow expectations to rise, and a false sense of security to set in... this is where the virus will be taking advantage, as it creates variants, and penetrates through populations So there... INCOMING!
C
by Auguraltrader
2
US500 S&P500 Bull market Hello, can you help me? I started to worry about the world of trading in January 2020 and shortly after when the pandemic started and we were confined it was a very useful and interesting hobby. Since the pandemic began and with the confinement, I took courses on the stock market, I read, searched, informed, understood and learned a lot. MANY have earned with platforms like Robinhood ... big amounts of money and that's great but watch out, don't underestimate financial intelligence. From May 2020 until today I have published 65 investment ideas and before this shitty year is over I will reach 100 Thank you for your time share and support L.E.D SPAIN 29/12/2020
U
by wallstreetstocks
US Markets are "gonna' get it"?Hello Traders! Happy start of the week. I hope you are having a good end of the year holiday. :D In this idea we will talk a little more about the outlook of the US markets, mainly due to the characteristics of the recent rally, which has brought several indexes to all-time highs, once again. The recent news of the stimulus packages approval in the US has resulted in optimism as the markets had a lot of uncertainty (and fear) that government aid would stop. However, these good news doesn’t seem to have had a very significant impact on the price, as there is growing fear about a new wave of lockdowns. These concerns arise from the lockdowns we’ve seen in various European countries, which has caused a risk-off sentiment in the markets again. This combined with doubts about the vaccine's distribution due to the required storage temperatures, raises even more concerns. If we analyze the message on the volume that the market leaves us, we can see how, repeatedly, when the market rallies, the volume decreases, which ends up causing the rally to be weak, and to run out of further progress. On the other hand, we can see that as the volume increases, the market begins to show dumps in the price, which reflects a high bearish interest. In the same way that we commented in the past analysis on the US markets, this is nothing more than a factor to consider within our trading plans, since in summary, the market tells us "Hmm, I’ll go up a bit but dumping like a rock seems more appealing to me", and while this is not a direct message to take trades, it is something that we must consider when conducting our analysis. I hope this post helps you! Remember to leave your opinion in the comments. As always, no matter what your perspective is about the market, you gotta’ plan your trades and trade your plan!
CME_MINI:ES1!Short
by FernandoBorea
Covid-19 Scan of North Europe and North AmericaQuick scan for Northern Europe shows that Sweden is spiking rathe parabolic. They went for herd immunity, and recently only backtracked to making mask wearing mandatory. Quite obvious what we are dealing with and there is no two ways about it. The neighbour, Finland, which has been out of the news is actually similarly spiking, albeit slightly moderated. Russia is similar with a spike that is appearing to be slowing slightly. To the south, Poland is better off with a plateau incoming. Clearly, Northern/Eastern Europe is is no better shape than Western Europe. Stay safe and healthy. Blessed Christmas to everyone there...
C
by Auguraltrader
COVID-19 check-in on Singapore, Malaysia, Indonesia and ChinaSimilarly to previous scan set up... Singapore numbers are rising, heads up given weeks ago, and still continue to rise... once the MACD histogram crosses above zero, it is highly likely to be the next wave. Having said that, you can see China’s chart is just about starting up (ahead for Singapore), and after Chinese New Year, would likely be a spike or Wave 2 in motion, IMHO, it has already started for China. Indonesia is accelerating again in their initial wave... Malaysia is deep into Wave 2 and has not peaked out yet. Risks are there, and honestly does not appear that a vaccine would quell the pandemic. Perhaps mitigate the spread and moderate its acceleration somewhat. So be prepared. We are getting data heads up weeks, maybe months in advance.
C
by Auguraltrader
Western European COVID-19 forces a close(er) ChristmasA quick screen of the COVD-19 situation in the Western European countries of Great Britain, France, Germany and Italy shows that all have had a spike in recent months. The MACD histograms actually decipher the rate of acceleration of the spike in cases. Hence, the MACD histograms really need to go below zero to get a deceleration in the number of COVID-19 cases. From here, we can see... Great Britain is moderating it’s spike. France is slowing down the spike somewhat, nonetheless still increasing, albeit at a moderated pace. Germany is still in acceleration phase of their Wave 2, and it would may be months before it decelerates. Italy, like GB , is moderating slightly. So much for Christmas... it would be one that returns everyone to basic nuclear family, where Christmas is less consumer driven, and more family orientated. While we know the deteriorating conditions, we pray that families get closer and bond better through this period. God bless... Merry Christmas, Joyeux Noel. Stay safe, stay healthy.
C
by Auguraltrader